Type / Class
Equity / Ordinary Shares (represented by American Depository Shares)
Shares outstanding
72.8M
Number of holders
43
Total 13F shares, excl. options
30.7M
Shares change
-1.1M
Total reported value, excl. options
$235M
Value change
-$5.69M
Number of buys
22
Number of sells
-19
Price
$7.65

Significant Holders of Abivax S.A. - Ordinary Shares (represented by American Depository Shares) (ABVX) as of Q2 2025

52 filings reported holding ABVX - Abivax S.A. - Ordinary Shares (represented by American Depository Shares) as of Q2 2025.
Abivax S.A. - Ordinary Shares (represented by American Depository Shares) (ABVX) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 30.7M shares of 72.8M outstanding shares and own 42.12% of the company stock.
Largest 10 shareholders include TCG Crossover Management, LLC (6.06M shares), Deep Track Capital, LP (3.48M shares), ADAR1 Capital Management, LLC (3.07M shares), Cormorant Asset Management, LP (2.13M shares), Caligan Partners LP (1.67M shares), Nantahala Capital Management, LLC (1.48M shares), FRANKLIN RESOURCES INC (1.37M shares), VR ADVISER, LLC (1.35M shares), GREAT POINT PARTNERS LLC (1.29M shares), and Octagon Capital Advisors LP (1.27M shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.